The increasingly acrimonious battle between Endurance Specialty and Aspen Insurance – sparked by an unsolicited $3.2 billion bid for Aspen by Endurance – took a new twist late last week when Aspen moved to block the bid through a shareholders’ rights plan, which Endurance described as a “poison pill”.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
To request a FREE 2-week trial subscription, use the same link but select the 'trial' option in the dropdown box. NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Aspen Insurance, Endurance Specialty, Shareholders' Rights Plan, Michael McGuire
